-
EP0030815
European procedure
Extract from the Register of European Patents
EP About this file: EP0030815
| EP0030815 - Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses, and pharmaceutical compositions comprising this antibody [Right-click to bookmark this link] | Status | Patent revoked Status updated on 23.10.1998 Database last updated on 03.04.2025 | Most recent event Tooltip | 17.04.2015 | Change - lapse in a contracting state State(s) deleted from list of lapses: CH, LI | published on 20.05.2015 [2015/21] | Applicant(s) | For all designated states ORTHO PHARMACEUTICAL CORPORATION U.S. Route 202 P.O. Box 300 Raritan New Jersey 08869-0602 / US | [N/P] |
| Former [1981/25] | For all designated states ORTHO PHARMACEUTICAL CORPORATION U.S. Route 202 P.O. Box 300 Raritan New Jersey 08869-0602 / US | Inventor(s) | 01 /
Kung, Patrick Chung-Shu 1096 Rector Road Bridgewater New Jersey / US | 02 /
Goldstein, Gideon 30 Dorison Drive Short Hills New Jersey / US | [1981/25] | Representative(s) | Jones, Alan John, et al CARPMAELS & RANSFORD 43 Bloomsbury Square London, WC1A 2RA / GB | [N/P] |
| Former [1981/25] | Jones, Alan John, et al CARPMAELS & RANSFORD 43 Bloomsbury Square London, WC1A 2RA / GB | Application number, filing date | 80304350.4 | 03.12.1980 | [1981/25] | Priority number, date | US19790100072 | 04.12.1979 Original published format: US 100072 | [1981/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0030815 | Date: | 24.06.1981 | Language: | EN | [1981/25] | Type: | A3 Search report | No.: | EP0030815 | Date: | 30.12.1981 | Language: | EN | [1981/52] | Type: | B1 Patent specification | No.: | EP0030815 | Date: | 15.05.1985 | Language: | EN | [1985/20] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 26.10.1981 | Classification | IPC: | C12P1/00, C12N5/00, C12N15/00, G01N33/50, A61K39/395, // C12R1/91 | [1985/20] | CPC: |
C07K16/2896 (EP,US);
A61P37/00 (EP);
A61K38/00 (EP,US);
Y10S530/808 (EP,US)
|
| Former IPC [1981/25] | C12P1/00, C12N5/00, C12N15/00, G01N33/54, A61K39/395, // C12R1/91 | Designated contracting states | AT, BE, CH, DE, FR, GB, IT, LI, NL, SE [1981/25] | Title | German: | Hybridzellinie zur Herstellung monoklonaler Antikörper gegen ein menschliches Prothymozyt-Antigen; Antikörper und Verfahren zu seiner Herstellung; diagnostische und therapeutische Verwendungen und diesen Antikörper enthaltende pharmazeutische Zusammensetzungen | [1981/25] | English: | Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, method of preparation of this antibody, diagnostic and therapeutic uses, and pharmaceutical compositions comprising this antibody | [1981/25] | French: | Lignée de cellules hybrides pour la préparation d'anticorps monoclonaux contre un antigène prothymocyte humain; anticorps; procédé pour préparer cet anticorps, applications diagnostiques et thérapeutiques et compositions pharmaceutiques contenant cet anticorps | [1981/25] | Biological material | This application mentions deposited biological material, check the file for details | Examination procedure | 03.06.1982 | Examination requested [1982/33] | 26.09.1983 | Despatch of a communication from the examining division (Time limit: M04) | 07.11.1983 | Reply to a communication from the examining division | 25.05.1984 | Despatch of communication of intention to grant (Approval: ) | 31.07.1984 | Communication of intention to grant the patent | 19.09.1984 | Fee for grant paid | 19.09.1984 | Fee for publishing/printing paid | Opposition(s) | Opponent(s) | 01
11.02.1986
23.04.1986
ADMISSIBLE Behringwerke Aktiengesellschaft Postfach 11 40 D-35001 Marburg / DE | 02
11.02.1986
23.04.1986
ADMISSIBLE Dolder, Fritz Rosenbergstrasse 6 Postfach 558 CH-8304 Wallisellen / CH | 03
13.02.1986
23.04.1986
ADMISSIBLE Becton, Dickinson and Company Mack Centre Drive Paramus, New Jersey 07652 / US Opponent's representative Ruffles, Graham Keith Marks & Clerk LLP 62-68 Hills Road Cambridge CB2 1LA / GB | 04
14.02.1986
23.04.1986
ADMISSIBLE Boehringer Mannheim GmbH Patentabteilung Sandhofer Strasse 116 D-68298 Mannheim / DE Opponent's representative Fincke, Karl Theodor Patentanwälte H. Weickmann, Dr. K. Fincke F.A. Weickmann, B. Huber Dr. H. Liska, Dr. J. Prechtel, Dr. B. Böhm Postfach 86 08 20 D-81635 München / DE | [N/P] |
| Former [1986/15] | |||
| Opponent(s) | 01
11.02.1986
23.04.1986
ADMISSIBLE Behringwerke Aktiengesellschaft Postfach 11 40 D-35001 Marburg / DE | ||
| 02
11.02.1986
23.04.1986
ADMISSIBLE Dolder, Fritz Rosenbergstrasse 6 Postfach 558 CH-8304 Wallisellen / CH | |||
| 03
13.02.1986
23.04.1986
ADMISSIBLE Becton, Dickinson and Company Mack Centre Drive Paramus, New Jersey 07652 / US Opponent's representative Ruffles, Graham Keith MARKS & CLERK, 57-60 Lincoln's Inn Fields London WC2A 3LS / GB | |||
| 04
14.02.1986
23.04.1986
ADMISSIBLE Boehringer Mannheim GmbH Patentabteilung Sandhofer Strasse 116 D-68298 Mannheim / DE Opponent's representative Fincke, Karl Theodor, Dipl.-Phys. Dr. Patentanwälte H. Weickmann, Dr. K. Fincke F.A. Weickmann, B. Huber Dr. H. Liska, Dr. J. Prechtel, Dr. B. Böhm Postfach 86 08 20 D-81635 München / DE | 24.04.1986 | Invitation to proprietor to file observations on the notice of opposition | 01.10.1987 | Reply of patent proprietor to notice(s) of opposition | 04.07.1988 | Despatch of a communication from the opposition division (Time limit: M06) | 13.01.1989 | Reply to a communication from the opposition division | 20.08.1991 | Despatch of a communication from the opposition division (Time limit: M11) | 23.07.1992 | Reply to a communication from the opposition division | 06.05.1993 | Despatch of a communication from the opposition division (Time limit: M04) | 16.09.1993 | Reply to a communication from the opposition division | 09.03.1994 | Date of oral proceedings | 22.04.1994 | Despatch of minutes of oral proceedings | 23.06.1998 | Legal effect of revocation of patent [1998/50] | 23.06.1998 | Despatch of communication that the patent will be revoked | Appeal following opposition | 31.05.1994 | Appeal received No. T0512/94 | 18.08.1994 | Statement of grounds filed | 23.06.1998 | Result of appeal procedure: revocation of the patent | 23.06.1998 | Date of oral proceedings | 11.03.1998 | Minutes of the oral proceedings despatched | Fees paid | Renewal fee | 18.12.1982 | Renewal fee patent year 03 | 10.12.1983 | Renewal fee patent year 04 | 13.12.1984 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2015/21] |
| Former [2000/52] | CH | 15.05.1985 | |
| LI | 15.05.1985 | Documents cited: | Search | [ ] - BIOLOGICAL ABSTRACTS, vol. 69, no. 10, 1980, Philadelphia, USA, P. LAKE et al."Production and characterization of cytotoxic Thy-1 antibody secreting hybrid cell lines: detection of thymus derived cell subsets", page 6917, abstract 64810 & EUR. J. IMMUNOL. 9 (11), 875-86, 1979 | [ ] - BIOLOGICAL ABSTRACTS, vol. 68, no. 5, 1979, Philadelphia, USA, R. DULBECCO et al " Role of Thy-1 antigen in the in vitro differentiation of a rat mammary cell line", page 2853, abstract 28600 & PROC. NATL. ACAD. SCI, USA 76(4), 1848-52, 1979 | [D] - SCIENCE, vol. 206, October 19, 1979, P.C. KUNG et al. "Monoclonal antibodies defining distinctive human T cell surface antigens", pages 347-349 | [AD] - NATURE, vol. 256, August 7, 1975, G. KOHLER et al. "Continuous cultures of fused cells secreting antibody of predefined specificity", pages 495-497. | [AD] - CHEMICAL & ENGINEERING NEWS, vol. 57, no. 1, January 1, 1979, J.L. FOX "Antibody reagents revolutionizing immunology", pages 15-17. | [XP] - TRANSPLANTATION PROCEEDINGS, vol. 12, no. 3, Suppl. 1, September 1980, P.C. KUNG et al. "Strategies for generating monoclonal antibodies defining human T-lymphocyte differentiation antigens", pages 141-146. |